Veristat is excited to join clinical research professionals to discuss the key challenges faced by small to mid-sized biotech and pharma companies at the Outsourcing in Clinical Trials Southeast 2017 event.
Veristat to Attend Bio Europe Spring 2017 Event
February 27, 2017
Join Veristat and nearly 2,500 professionals from biotech, pharma, finance and life sciences industry across Europe’s most innovative biopharma clusters at the Bio Europe Spring 2017 event.
Let's Honor Rare Disease Day 2017 | February 28, 2017
February 23, 2017
What is Rare Disease Day?
This year's Rare Disease Day is being celebrated on Tuesday, February 28, 2017 and it marks the tenth year that Rare Disease Day has been celebrated. On this day, thousands of organizations from around the world will hold awareness-raising activities centered on the theme of raising awareness for rare disease research.
Veristat is excited to join over 700 clinical research professionals from the bay area to discuss strategies for clinical outsourcing and address the clinical operations challenges that arise throughout the clinical development and submission process at the Outsourcing in Clinical Trials West Coast 2017 conference.
Veristat is excited to announce that it has officially opened its new office in Morrisville, North Carolina.
We are hosting an opening reception on Thursday, March 2, 2017 to celebrate the opening of this new office.
Veristat to Exhibit at the 2016 MassBio CRO/CMO Symposium
November 29, 2016
Join Veristat and more than 300 local attendees to discuss and evaluate the best practices that have evolved in shortening time to market at the 5th Annual MassBio CRO/CMO Symposium.
Join Veristat at the ASH Annual Meeting & Exposition, the world’s largest hematology conference geared towards clinicians, researchers and scientists who are looking to further the understanding, diagnosis, treatment, and prevention of blood disorders. Today, the ASH annual meeting attracts more than 20,000 attendees from all over the world.
Veristat to present at Harvard Drug Development Boot Camp
November 14, 2016
Come join Veristat and a panel of drug development experts for a two day intensive boot camp targeted for executive level leaders who make drug development decisions on a daily basis.
John Balser to Moderate Forum on Adaptive Designs in Clinical Trials
November 2, 2016
Come join the conversation being moderated by John Balser, PhD, President of Veristat. Bring your challenging questions and be prepared to share your experiences with adaptive designs.
Have you ever wondered how biotech and pharma companies make informed decisions as to whether an adaptive design would be useful in their development programs?